Opendata, web and dolomites

SELNET SIGNED

Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SELNET project word cloud

Explore the words cloud of the SELNET project. It provides you a very rough idea of what is the project "SELNET" about.

translational    brazil    referral    spain    rare    strategic    healthcare    diagnoses    lack    delayed    30    biobanks    cancersrare    drugs    multidisciplinary    france    community    tumor    heterogeneous    registry    survival    subtypes    hindered    data    mexico    groups    accounting    rcs    reference    argentina    tumors    international    therapies    financial    risk    practitioners    group    poor    incorrect    drivers    cancer    cancers    preclinical    costa    adherence    countries    rica    patient    network    diagnosis    quality    adult    education    cpgs    create    clinical    sarcoma    model    trials    pathologists    observational    specialists    care    tissues    improvement    boards    hence    prognosis    absence    solid    expert    collaborative    threatening    guidelines    core    death    creation    appropriate    centers    medical    soft    scarcity    sarcomas    models    incidence    worsen    mtbs    22    replicable    american    relapse    patients    intercontinental    representing    bone    caribbean    policies    deaths    life    italy    selnet       pathological    peru    unavailability    latin    malignancies    10    prognostic    celac    validating    conduct    complete    networks    barrier    expertise   

Project "SELNET" data sheet

The following table provides information about the project.

Coordinator
SERVICIO ANDALUZ DE SALUD 

Organization address
address: AVENIDA DE LA CONSTITUCION 18
city: SEVILLA
postcode: 41071
website: http://www.sas.junta-andalucia.es/principal/default.asp

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 3˙294˙306 €
 EC max contribution 3˙092˙400 € (94%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SERVICIO ANDALUZ DE SALUD ES (SEVILLA) coordinator 792˙000.00
2    CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD FR (LYON) participant 486˙000.00
3    FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI IT (Milan) participant 450˙000.00
4    ISTITUTO ORTOPEDICO RIZZOLI IT (BOLOGNA) participant 432˙000.00
5    GRUPO ESPANOL DE INVESTIGACION EN SARCOMAS ASOCIACION ES (MADRID) participant 306˙000.00
6    ALEXANDER FLEMING SA AR (BUENOS AIRES) participant 194˙400.00
7    FUNDACION AMOR ESPERANZA Y VIDA CR (HEREDIA) participant 180˙000.00
8    INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-INEN PE (LIMA) participant 176˙400.00
9    SARCOMA PATIENTS EURONET EV DE (WOLFERSHEIM) participant 75˙600.00
10    FUNDACAO ANTONIO PRUDENTE BR (SAO PAULO) participant 0.00
11    Instituto Nacional de Cancerología MX (MEXICO) participant 0.00

Map

 Project objective

Rare cancersRare cancers are associated with poor survival, accounting for 22% of new cancer diagnoses in Europe, and 30% of cancer deaths. Sarcomas are a heterogeneous group of life-threatening rare solid malignancies affecting soft and bone tissues, representing 10% of rare tumors and around 2% of adult tumors, with an incidence of 5.9/100,000/year in Europe. Appropriate management of sarcoma patients is hindered by the absence of referral policies to reference centers (RCs), incorrect or delayed diagnosis, non-adherence of therapies to clinical practice guidelines (CPGs), and lack of expertise by practitioners, which increases the risk of relapse and death. These problems worsen in the Community of Latin American and Caribbean States (CELAC) due to the scarcity or complete unavailability of RCs, expert pathologists, multidisciplinary tumor boards (MTBs), new cancer drugs, clinical trials, patient registry data, and financial resources. Hence, the SELNET project seeks to create a European and Latin American multidisciplinary network of clinical and translational specialists to improve diagnosis and clinical care in sarcomas, with the aim of validating a collaborative model replicable in other rare tumors and in other countries. Recognized cancer centers and research groups of Spain, Italy, France, Mexico, Brazil, Argentina, Costa Rica, and Peru will contribute to better rare cancer care by fostering RCs, healthcare barrier analysis, CPGs, and medical education as key improvement drivers. The core of the research work focuses on improving diagnosis and prognosis of sarcoma patients through the creation of pathological diagnosis networks, MTBs, the conduct of an international registry-based observational study to assess clinical management quality and prognostic factors, and the implementation of an strategic translational research program to develop intercontinental sarcoma biobanks, preclinical models, and a translational study with drugs in rare sarcoma subtypes.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SELNET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SELNET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More